MRC1 and cancer: Beyond WRN disruption, the MMR signatures as well as other mutation signatures can predict sensitivity to many perturbations, including those that the MSI status nor the other genetic markers would not predict (Supplementary Fig. 9a; we note that the converse is also true, at least for the few cancer types where MSI labels are available).